Gregory J. Herrema - Oct 18, 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Role
Director
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Oct 18, 2023
Transactions value $
$0
Form type
4
Date filed
10/25/2023, 02:46 PM
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock Award $0 +153K $0.00 153K Oct 18, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +230K $0.00 230K Oct 18, 2023 Common Stock 230K $0.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Telesis Bio Inc.'s (the "Issuer") Common Stock. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each such date, one third (1/3rd) of the RSUs shall vest annually following the Grant Date on the same day of the month as the Grant Date over three (3) years. "Grant Date" shall mean October 18, 2023.
F2 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the Shares subject to the Option shall vest in equal monthly installments following the Grant Date on the same day of the month as the Grant Date. "Grant Date" shall mean October 18, 2023.